Search Results 121-130 of 5438 for edward loftus

  1. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  2. Robert E. Sedlack, M.D., M.H.P.E.

    Sedlack, M.D., M.H.P.Ed, is a consultant at the Mayo Clinic in the division of Gastroenterology and Hepatology, and an Assistant Professor of Medicine. He ...

  3. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. A Study to Evaluate the Long-Term Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis (UC) - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  5. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  6. Surgery - Doctors - Mayo Clinic

    Edward S. Ahn, M.D.. Pediatric Neurosurgeon. Rochester, MN ...

  7. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  8. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  9. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Contact information: Troy Ofstie R.N., CCRP. (507) 266-4728. Contact UsIBDresearch@mayo.edu. Contact us for the latest status. More ...

  10. Publications - Nayantara Coelho-Prabhu, M.B.B.S. - Mayo Clinic

    ... Loftus EV Jr. Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary ...